Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening.

Autor: Miglianico M; TropIQ Health Sciences, Nijmegen, The Netherlands., Bolscher JM; TropIQ Health Sciences, Nijmegen, The Netherlands., Vos MW; TropIQ Health Sciences, Nijmegen, The Netherlands., Koolen KJM; TropIQ Health Sciences, Nijmegen, The Netherlands., de Bruijni M; TropIQ Health Sciences, Nijmegen, The Netherlands., Rajagopal DS; TropIQ Health Sciences, Nijmegen, The Netherlands., Chen E; Calibr, a division of The Scripps Research Institute, La Jolla, California, United States of America., Kiczun M; Drug Discovery Unit, University of Dundee, Dundee, United Kingdom., Gray D; Drug Discovery Unit, University of Dundee, Dundee, United Kingdom., Campo B; Medicines for Malaria Venture, Geneva, Switzerland., Sauerwein RW; TropIQ Health Sciences, Nijmegen, The Netherlands., Dechering KJ; TropIQ Health Sciences, Nijmegen, The Netherlands. k.dechering@tropiq.nl.

Publikováno v: Communications biology [Commun Biol] 2023 Feb 23; Vol. 6 (1), pp. 216. Date of Electronic Publication: 2023 Feb 23.